JPMorgan Reviews Impact to Evolent Health (EVH) Amid Humana (HUM) News, Shares Gaining off LOD
Tweet Send to a Friend
JPMorgan analyst Anne Samuel reiterated an Overweight rating and $45.00 price target on Evolent Health (NYSE: EVH).The analyst comments "Following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
